ClinicalTrials.govpublic full text
Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
multiple myeloma, relapsed multiple myeloma, refractory multiple myeloma, vorinostat, bortezomib, doxil, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887134
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.